Invent Medic’s product Efemia Bladder Support evaluated by potential distributor in Germany

Report this content

Invent Medic announces that both users and gynaecologists in Germany gave overall positive feedback on Efemia in a recently completed evaluation by a potential distributor in Germany. Based on the results, it was decided that Invent Medic needs a distributor with a stronger focus on the retail market in Germany.

Invent Medic will take the conclusions from the evaluation into account when continuing to search for an optimal distribution partner in Germany. The information is also relevant for additional European markets.

“The positive response from both users and gynaecologists in Germany in this evaluation indicate that Efemia has a strong potential on the international market. Based on this, we see this evaluation as a step forward in Europe even though we will not move forward with this particular distributor,” says Invent Medic’s CEO Karin Bryder.

For information on Invent Medic Sweden AB, please contact: 
Karin Bryder, CEO
Phone: +46 723 81 17 10

This information is information that Invent Medic Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on April 04, 2019.

About Invent Medic
Invent Medic Sweden AB (Invent Medic) is a Swedish company developing innovative products with the aim to improve women’s health and quality of life. The company’s products are to be safe, effective and easy to use. The finished women’s health products are sold through the company’s Arcamea brand. Invent Medic’s first product, Efemia, is a CE-certified and patented medical technology product used to reduce stress urinary incontinence (SUI) that was shown to reduce urine leakage with 77 percent during usage in a clinical study. The product is based on the same scientific principle as the TVT method, the premier surgical treatment for SUI. Invent Medic’s share is listed on the Spotlight Stock Market with the ticker symbol IMS, and the share’s ISIN code is SE0007603402. More information can be found at and


Documents & Links